STRATEGY

We plan to fulfill our vision by acquisition of proprietary, niche medicinal products in selected European markets and further create product flow through partnerships and distribution agreements.

• High focus on hospital and critical care products
• An acquired product which over time does not fit the product portfolio is to be divested
• Acquisitions are made based on a low risk profile
• To offer our products at affordable and cost effective prices in all markets
• To operate our business while securing no “out of stock situations”
• To provide products which are manufactured at conditions which respect environmental concerns